A novel universal influenza vaccine targeting epitopes of limited variability

Project Information

UNIFLUVAC

Grant agreement ID: 812816

DOI

10.3030/812816

Project closed

EC signature date 10 August 2018

Start date 1 October 2018

End date 31 March 2020

Funded under

• EXCELLENT SCIENCE - European Research Council (ERC)

Total cost

€ 149 297,00

EU contribution

€ 149 297,00

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

A naturally protective epitope of limited variability as an influenza vaccine target

Author(s): Craig P. Thompson, José Lourenço, Adam A. Walters, Uri Obolski, Matthew Edmans, Duncan S. Palmer, Kreepa Kooblall, George W. Carnell, Daniel O’Connor, Thomas A. Bowden, Oliver G. Pybus, Andrew J. Pollard, Nigel J. Temperton, Teresa Lambe, Sarah C. Gilbert, Sunetra Gupta
Published in: Nature Communications, Issue 9/1, 2018, Page(s) 3859-3869, ISSN 2041-1723
Publisher: Nature Publishing Group
DOI: 10.1038/s41467-018-06228-8